- Home
- VVV vs ALKS Comparison
VVV vs ALKS Comparison
Compare VVV & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVV
- ALKS
- Stock Information
- Founded
- VVV 1866
- ALKS 1987
- Country
- VVV United States
- ALKS Ireland
- Employees
- VVV N/A
- ALKS N/A
- Industry
- VVV Major Chemicals
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- VVV Industrials
- ALKS Health Care
- Exchange
- VVV Nasdaq
- ALKS Nasdaq
- Market Cap
- VVV 4.8B
- ALKS 5.1B
- IPO Year
- VVV 2016
- ALKS 1991
- Fundamental
- Price
- VVV $35.26
- ALKS $27.55
- Analyst Decision
- VVV Buy
- ALKS Strong Buy
- Analyst Count
- VVV 12
- ALKS 13
- Target Price
- VVV $42.33
- ALKS $40.38
- AVG Volume (30 Days)
- VVV 1.7M
- ALKS 2.0M
- Earning Date
- VVV 08-06-2025
- ALKS 07-29-2025
- Dividend Yield
- VVV N/A
- ALKS N/A
- EPS Growth
- VVV 56.15
- ALKS N/A
- EPS
- VVV 2.05
- ALKS 2.09
- Revenue
- VVV $1,674,400,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- VVV $6.67
- ALKS N/A
- Revenue Next Year
- VVV $15.40
- ALKS $3.33
- P/E Ratio
- VVV $17.16
- ALKS $13.47
- Revenue Growth
- VVV 9.56
- ALKS N/A
- 52 Week Low
- VVV $31.02
- ALKS $25.56
- 52 Week High
- VVV $47.08
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- VVV 40.21
- ALKS 46.68
- Support Level
- VVV $35.32
- ALKS $25.72
- Resistance Level
- VVV $36.45
- ALKS $27.29
- Average True Range (ATR)
- VVV 0.97
- ALKS 1.04
- MACD
- VVV -0.29
- ALKS -0.11
- Stochastic Oscillator
- VVV 7.42
- ALKS 46.62
About VVV Valvoline Inc.
Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.